A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
Authors
Keywords
-
Journal
Clinical Epigenetics
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-30
DOI
10.1186/s13148-021-01119-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-wide plasma DNA methylation features of metastatic prostate cancer
- (2020) Anjui Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- Prostate cancer reactivates developmental epigenomic programs during metastatic progression
- (2020) Mark M. Pomerantz et al. NATURE GENETICS
- The DNA methylation landscape of advanced prostate cancer
- (2020) Shuang G. Zhao et al. NATURE GENETICS
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
- (2019) Elin Thysell et al. Molecular Oncology
- Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity
- (2018) Annika Nordstrand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response
- (2017) Erik Bovinder Ylitalo et al. EUROPEAN UROLOGY
- Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
- (2017) Bram De Laere et al. EUROPEAN UROLOGY
- The importance of DNA methylation in prostate cancer development
- (2017) Charles E. Massie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein CodingYIPF6inARAmplified Prostate Cancer Bone Metastases
- (2017) Erik Djusberg et al. PROSTATE
- Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
- (2017) Shuang G. Zhao et al. JAMA Oncology
- Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
- (2016) S. You et al. CANCER RESEARCH
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia
- (2016) Magnus Borssén et al. PEDIATRIC BLOOD & CANCER
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Smooth Muscle Cell Genome Browser: Enabling the Identification of Novel Serum Response Factor Target Genes
- (2015) Moon Young Lee et al. PLoS One
- Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
- (2014) Martin J. Aryee et al. BIOINFORMATICS
- Validation Study of Genes with Hypermethylated Promoter Regions Associated with Prostate Cancer Recurrence
- (2014) M. Stott-Miller et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants
- (2013) Emma Jernberg et al. PLoS One
- A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
- (2012) Andrew E. Teschendorff et al. BIOINFORMATICS
- Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
- (2011) T. W. Friedlander et al. CANCER RESEARCH
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
- (2011) Emma Hörnberg et al. PLoS One
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells
- (2008) Giovanni Luca Gravina et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now